Clinical Trial Update: Safety & Immunogenicity of HIV Vaccines in Healthy Kenyan Adults [Phase 1, Phase 2]

View source ↗

Summary

This trial update reports safety and immunogenicity results for HIV vaccine candidates tested in healthy Kenyan adults in Phase 1/2 studies.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acquired Immunodeficiency Syndrome

Drugs mentioned

• HIV vaccine candidates

Snippet

Sponsor: University of Oxford | Conditions: AIDS | Phase 1, Phase 2 | Status: COMPLETED